Alteration in Serum Leptin Correlates with Alterations in Serum N-Telopeptide of Collagen type I and Serum Osteocalcin During the Progression of Osteoporosis in Ovariectomized Rats

Clinical Chemistry and Laboratory Medicine

Volumn 43, Issue 12, 2005, Pages 1359-1365

  Stavropoulou, Anastasia ^a   Christopoulou, Gina E ^a   Anastassopoulos, George ^b   Panteliou, Sofia D ^b   Lyritis, George P ^c   Spiliotis, Bessie E ^d   Karamanos, Nikos K ^b   Panagiotopoulos, Elias ^d   Lambiris, Elias ^d  

^a Medical School   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

^d UNIVERSITY HOSPITAL OF PATRAS   (Greece)

Author keywords

leptin; N telopeptide of collagen type I (NTx); osteocalcin; osteoporosis; ovariectomy

Indexed keywords

BIOLOGICAL MARKER; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE I TRIMERIC CROSS LINKED PEPTIDE; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; LEPTIN; OSTEOCALCIN; PEPTIDE;

ANIMAL; ARTICLE; BLOOD; BONE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; METABOLISM; METHODOLOGY; OSTEOPOROSIS; OVARIECTOMY; RAT; TIME;

ANIMALS; BIOLOGICAL MARKERS; BONE AND BONES; COLLAGEN; COLLAGEN TYPE I; FEMALE; LEPTIN; OSTEOCALCIN; OSTEOPOROSIS; OVARIECTOMY; PEPTIDES; RATS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33644875532     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2005.232     Document Type: Article

References (27)

1. Looker AC, Bauer DC, Chesnut CH III, Gundberg CM, Hochberg MC, Klee G, et al. Clinical use of biochemical markers of bone remodeling: current status and future directions. Osteoporos Int 2000; 11: 467-480.
2. Watts NB. Clinical utility of biochemical markers of bone remodelling. Clin Chem 1999; 45: 1359-1368.
3. Peichl P, Griesmacher A, Marteau R, Hejc S, Kumpan W, Muller MM, et al. Serum crosslaps in comparison to serum osteocalcin and urinary bone resorption markers. Clin Biochem 2001; 34: 131-139.
4. Pectasides D, Farmakis D, Nikolaou M, Kanakis I, Kostopoulou V, Papakonstantinou I, et al. Diagnostic value of bone remodeling markers in the diagnosis of bone metastases in patients with breast cancer. J Pharm Biomed Anal 2005; 37: 171-176.
5. Kanakis I, Nikolaou M, Pectasides D, Kiamouris C, Karamanos NK. Determination and biological relevance of serum cross-linked type I collagen N-telopeptide and bone-specific alkaline phosphatase in breast metastatic cancer. J Pharm Biomed Anal 2004; 34: 827-832.
6. Christenson RH. Biochemical markers of bone metabolism: an overview. Clin Biochem 1997; 30: 573-593.
7. Fu JY, Muller D. Simple rapid enzyme-linked immunosorbent assay (ELISA) for the determination of rat osteocalcin. Calcif Tissue Int 1999; 64: 229-233.
8. Chung KW, Kim MR, Yoo SW, Kwon DJ, Lim YT, Kim JH, et al. Can bone turnover markers correlate bone mass at the hip and spine according to menopausal period? Arch Gynecol Obstet 2000; 264: 119-123.
9. Cräciun AM, Vermeer C, Eisenwiener H, Drees N, Knapen MH. Evaluation of a bead-based enzyme immunoassay for the rapid detection of osteocalcin in human serum. Clin Chem 2000; 46: 252-257.
10. Medh RD, Thompson EB. Hormonal regulation of physiological cell turnover and apoptosis. Cell Tissue Res 2000; 301: 101-124.
11. Takeda S, Elefteriou F, Levasseur R, Li X, Zhao L, Parker KL, et al. Leptin regulates bone formation via the sympathetic nervous system. Cell 2002; 111: 305-317.
12. Thomas T. The complex effects of leptin on bone metabolism through multiple pathways. Curr Opin Pharmacol 2004; 4: 295-300.
13. Cock TA, Auwerx J. Leptin: cutting the fat off the bone. Lancet 2003; 362: 1572-1574.
14. Reseland JE, Gordeladze JO. Role of leptin in bone growth: central player or peripheral supporter? FEBS Letters 2002; 528: 40-2.
15. Sims NA, Morris HA, Moore RJ, DurbridgeTC. Increased bone resorption precedes increased bone formation in the ovariectomized rat. Calcif Tissue Int 1996; 59: 121-127.
16. Flieger J, Karachalios T, Khaldi L, Raptou P, Lyritis G. Mechanical stimulation in the form of vibration prevents postmenopausal bone loss in ovariectomized rats. Calcif Tissue Int 1998; 63: 510-514.
17. Turner RT, Maran A, Lotinun S, Hefferan T, Evans GL, Zhang M, et al. Animal models for osteoporosis. Rev Endocr Metab Dis 2001; 2: 117-127.
18. Thompson DD, Simmons HA, Pirie CM, Ke HZ. FDA guidelines and animal models of osteoporosis. Bone 1995; 17: 125S-133S.
19. Jee WS, Yao W. Overview: animal models of osteopenia and osteoporosis. J Musculoskelet Neuronal Interact 2001; 1: 193-207.
20. Morris HA, Porter SJ, Durbridge TC, Moore RJ, Need AG, Nordin BE. Effects of oophorectomy on biochemical and bone variables in the rat. Bone Miner 1992; 18: 133-142.
21. Pinilla L, Seoane LM, Gonzalez L, Carro E, Aguilar E, Casanueva FF, et al. Regulation of serum leptin levels by gonadal function in rats. Eur J Endocrinol 1999; 140: 468-473.
22. Chen Y, Heiman ML. Increased weight gain after ovariectomy is not a consequence of leptin resistance. Am J Physiol Endocrinol Metab 2001; 280: 315-322.
23. Meli R, Pacilio M, Raso GM, Esposito E, Coppola A, Nasti A, et al. Estrogen and raloxifene modulate leptin and its receptor in hypothalamus and adipose tissue from ovariectomized rats. Endocrinology 2004; 145: 3115-3121.
24. Ainslie DA, Morris MJ, Wittert G, Turnbull H, Proietto J, Thorburn AW. Estrogen deficiency causes central leptin insensitivity and increased hypothalamic neuropeptide Y. Int J Obes Relat Metab Disord 2001; 25: 1680-1688.
25. Gordeladze JO, Drevon CA, Syversen U, Reseland JE. Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: impact on differentiation markers, apoptosis and osteoclastic signalling. J Cell Biochem 2002; 85: 825-836.
26. Burguera B, Hofbauer LC, Thomas T, Gori F, Evans GL, Khosla S, et al. Leptin reduces ovariectomy-induced bone loss in rats. Endocrinology 2001; 142: 3456-3463.
27. Amling M, Takeda S, Karsenty G. A neuro(endo)crine regulation of bone remodeling. BioEssays 2000; 22: 970-975.